ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System

August 26, 1977

Modeling: Like The Sims But No Graphics

November 26, 2010